July 20, 2026

Can Patients Switch to Biosimilar Aflibercept?

A 20-week INSIGHT extension suggests that switching from reference aflibercept to MYL-1701P maintained comparable safety, visual, and anatomic outcomes in patients with diabetic macular edema.

MDSpire News

July 14, 2026

Are GLP-1s Linked to Optic Neuropathy?

A nationwide Swedish cohort found a higher relative risk of anterior ischemic optic neuropathy among GLP-1 receptor agonist users, but the overall risks were low.

MDSpire News

July 13, 2026

GLP-1 RAs Associated With Small ION Risk Increase

In an observational US target trial emulation, glucagon-like peptide-1 receptor agonist initiation was associated with about 3 to 4 more ischemic optic neuropathy cases per 10,000 patients over 18 months than two comparator drug classes.

MDSpire News

July 01, 2026

The Benefits of Intravitreal Steroids During Vitrectomy

Triamcinolone acetonide enhances vitreous visualization, facilitates surgical maneuvers, and provides postoperative anti-inflammatory effects.

Retinal Physician

June 28, 2026

Blindness Linked to Higher Loneliness Scores

Analysis of more than 61,000 patients found higher odds of elevated loneliness scores among those reporting blindness and those with diabetic retinopathy, but not among patients with glaucoma or age-related macular degeneration.

MDSpire News

June 25, 2026

Diagnosis Gaps Mark Retinopathy Care

A US systematic review found substantial losses across diabetic retinopathy screening, diagnosis awareness, referral, and follow-up.

MDSpire News

June 18, 2026

AI Tool May Cut Macular Edema Referrals

An artificial intelligence–based optical coherence tomography pathway met noninferiority criteria for false-positive diabetic macular edema referrals and was associated with fewer referral decisions in a randomized clinical trial.

MDSpire News

June 17, 2026

Oculomics: Beyond the Buzzword

Joseph J. Pizzimenti, OD, FAAO, FORS, discusses the capabilities of oculomics in retina and neuro-ophthalmology,

Optometric Management

June 01, 2026

Nomogram Advances Retinopathy Screening

A simple, data-driven tool could help clinicians identify high-risk patients before vision is threatened

The Ophthalmologist

May 27, 2026

Retinal Age as Disease Biomarker

Fundus-based AI screening can indicate “retinal age” of patients, as well as flag systemic disease risks, says new study

The Ophthalmologist